|
MC-MSC.1 |
Phase III |
Behandlung der steroidrefraktären akuten Graft-versus-Host-Krankheit mit mesenchymalen Stromazellen im Vergleich zur besten verfügbaren Therapie (IDUNN) |
|
FLAMSACLAX |
Phase III |
Phase-I/II trial to assess the safety and efficacy of Venetoclax in addition to sequential conditioning with Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for allogeneic blood stem cell transplantation in patients with MDS, CMML or sAM |
|
INCA 34176-254 |
Phase II |
A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease Eudract Nr. 2022-502168-19-00 |
|
TASK |
AWB |
Therapieadhärenz bei Patienten mit Stammzelltransplantation bei einer hämatologischen Krebs-erkrankung (TASK) Fragebogenprojekt in Kooperation dem Universitätsklinikum Leipzig |
|
PIVOT |
Phase II |
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Neoplasia with IDH1 Mutation (PIVOT) |
Menü
